Apogee Therapeutics Income Statement (2022-2026) | APGE

Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 1.45M9.88M12.21M8.46M13.95M17.07M28.95M28.72M33.21M45.71M60.23M46.39M55.70M54.18M58.44M60.82M
Selling, General & Administrative (Quarter) 0.37M0.62M1.89M4.20M4.94M7.24M8.20M9.46M10.92M12.97M15.65M16.71M17.46M17.10M19.61M21.95M
Operating Expenses (Quarter) 1.82M10.51M14.10M12.66M18.89M24.30M37.16M38.18M44.12M58.69M75.88M63.10M73.17M71.28M78.06M82.77M
Operating Income (Quarter) -1.82M-10.51M-14.10M-12.66M-18.89M-24.30M38.21M-38.18M-44.12M-58.69M102.74M-63.10M-73.17M-71.28M153.87M-82.77M
EBIT (Quarter) -1.82M-10.51M-14.10M-12.66M-18.89M-24.30M38.21M-38.18M-44.12M-58.69M102.74M-63.10M-73.17M-71.28M153.87M-82.77M
Non-operating items
Interest & Investment Income (Quarter) 0.13M3.46M5.42M6.09M10.31M9.67M8.68M7.84M7.14M6.32M8.73M8.74M
Other Non Operating Income (Quarter) -9.15M0.09M0.13M3.46M-2.38M6.09M10.31M9.67M-23.32M7.84M7.14M6.32M8.73M8.74M
Non Operating Income (Quarter) -9.15M0.09M0.13M3.46M5.42M6.09M10.31M9.67M8.68M7.84M7.14M6.32M8.73M8.74M
Net income details
EBT (Quarter) -1.82M-10.51M-14.10M-12.53M-18.89M-20.84M43.63M-32.09M-33.82M-49.02M-67.20M-55.26M-66.02M-64.96M-69.33M-74.03M
Tax Provisions (Quarter) 0.02M0.08M0.07M0.06M0.06M0.08M
Profit After Tax (Quarter) -1.82M-19.66M-14.01M-12.53M-18.89M-20.84M-31.73M-32.09M-33.82M-49.02M-67.22M-55.34M-66.10M-65.02M-69.30M-74.11M
Income from Continuing Operations (Quarter) -1.82M-10.51M-14.10M-12.53M-18.89M-20.84M43.63M-32.09M-33.82M-49.02M-67.22M-55.34M-66.10M-65.02M-69.39M-74.11M
Consolidated Net Income (Quarter) -1.82M-10.51M-14.10M-12.53M-18.89M-20.84M43.63M-32.09M-33.82M-49.02M-67.22M-55.34M-66.10M-65.02M-69.39M-74.11M
Income towards Parent Company (Quarter) -1.82M-10.51M-14.10M-12.53M-18.89M-20.84M43.63M-32.09M-33.82M-49.02M-67.22M-55.34M-66.10M-65.02M-69.39M-74.11M
Net Income towards Common Stockholders (Quarter) -1.82M-19.66M-14.01M-12.53M-18.89M-20.84M-31.73M-32.09M-33.82M-49.02M-67.22M-55.34M-66.10M-65.02M-69.39M-74.11M
Additional items
EPS (Basic) (Quarter) -1.45-9.460.84-2.51-3.78-0.51-0.32-0.64-0.60-0.86-1.19-0.95-1.13-1.11-1.03-1.06
EPS (Weighted Average and Diluted) (Quarter) -1.45-9.460.84-2.51-3.78-0.51-0.32-0.64-0.60-0.86-1.19-0.95-1.13-1.11-1.03-1.06
Shares Outstanding (Weighted Average) (Quarter) 1.25M1.52M2.46M5.00M5.00M41.23M25.01M50.19M56.52M54.51M55.19M58.20M58.31M58.77M60.69M69.67M
Shares Outstanding (Diluted Average) (Quarter) 1.25M1.52M2.46M5.00M5.00M17.21M25.01M50.19M53.35M54.51M55.19M58.20M58.43M58.77M60.69M69.67M
EBITDA (Quarter) -1.82M-19.66M-14.01M-12.53M-18.89M-20.70M-31.54M-32.60M-33.93M-45.46M102.74M-63.10M-73.17M-71.28M153.87M-82.77M
Tax Rate (Quarter) -0.03%-0.15%-0.11%-0.09%-0.09%-0.11%